Dow Jones (DJIA) Today: E I Du Pont De Nemours & Company (DD) Lower

Holding back the Dow today is E I du Pont de Nemours & Company (NYSE:DD), which is lagging the broader Dow index with a 36-cent decline (-0.5%) bringing the stock to $77.96.

By Naomi Hossain , Mar 6, 2015 4:02 PM EST

Editor's Note: Any reference to TheStreet Ratings and its underlying recommendation does not reflect the opinion of TheStreet, Inc. or any of its contributors including Jim Cramer or Stephanie Link

The

Dow Jones Industrial Average

(

^DJI

) is trading down 288.0 points (-1.6%) at 17,847 as of Friday, Mar 6, 2015, 3:41 p.m. ET. During this time, 304.2 million shares of the 30 Dow components have changed hands vs. an average daily trading volume of 374 million. The NYSE advances/declines ratio sits at 425 issues advancing vs. 2,707 declining with 80 unchanged.

EXCLUSIVE OFFER: Jim Cramer's Protégé, Dave Peltier, only buys Stocks Under $10 that he thinks could potentially double. See what he's trading today with a 14-day FREE pass.

Holding back the Dow today is

E I du Pont de Nemours & Company

(NYSE:

), which is lagging the broader Dow index with a 36-cent decline (-0.5%) bringing the stock to $77.96. This single loss is lowering the Dow Jones Industrial Average by 2.72 points or roughly accounting for 0.9% of the Dow's overall loss. Volume for E I du Pont de Nemours & Company currently sits at 6.3 million shares traded vs. an average daily trading volume of 3.8 million shares.

E I du Pont de Nemours & Company has a market cap of $70.73 billion and is part of the basic materials sector and chemicals industry. Shares are up 5.9% year-to-date as of Thursday's close. The stock's dividend yield sits at 2.4%.

E. I. du Pont de Nemours and Company operates as a science and technology based company worldwide. The company's Agriculture segment offers corn hybrid, soybean, canola, sunflower, sorghum, inoculants, seed products, wheat, rice, herbicides, fungicides, and insecticides.

TheStreet Ratings rates E I du Pont de Nemours & Company as a

buy

. The company's strengths can be seen in multiple areas, such as its solid stock price performance, impressive record of earnings per share growth, increase in net income, largely solid financial position with reasonable debt levels by most measures and reasonable valuation levels. Although the company may harbor some minor weaknesses, we feel they are unlikely to have a significant impact on results.